Applied Nutrition PLC

Chief Executive Thomas Ryder and COO Steven Granite plan to sell about 6,000,000 ordinary shares (around 2.40% of issued share capital) through an accelerated bookbuilding process. Together the selling shareholders currently hold 100,170,095 ordinary shares (approx. 40.07%). Panmure Liberum is acting as sole bookrunner; price and final quantity will be set at the close of the process. After the placement, a 180‑day lock‑up agreement will apply to the remaining shares; Applied Nutrition is not participating in the transaction and will receive no proceeds. » More on de.investing.com

Applied Nutrition expects revenue of about £160m for fiscal 2026 (+≈50%) and adjusted EBITDA of around £43.3m (+≈40%), both metrics above consensus. The shares jumped 5.15% to 338.05 pence and are trading near the 52-week high. The company signals a stronger-growth 2027 and is expanding production in North America, including by acquiring assets of the Nutrablend Group and through new licensing and commercial partnerships. Partnerships with retailers such as Holland & Barrett and new US listings are expected to support further revenue growth. » More on de.investing.com

Applied Nutrition said financial results for the year ending 31 July 2026 are expected to be about 10% above the current market consensus. The company attributes this to continued momentum and a strong order book and expects a particularly strong first half in the main season for health, fitness and well‑being. Before the announcement, consensus expectations were revenue of £122.3m and adjusted EBITDA of £34.4m. » More on de.investing.com